Modulatory Effects of Nicotine on neuroHIV/neuroAIDS

Abbondanzo SJ, Chang SL (2014) HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging. PLoS One 9:e105256

Akkina R (2013) New generation humanized mice for virus research: Comparative aspects and future prospects. Virology 435:14–28

Albuquerque EX, Pereira EF, Alkondon M, Rogers SW (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89:73–120

Amor S, Puentes F, Baker D, van der Valk P (2010) Inflammation in neurodegenerative diseases. Immunology 129:154–169

Ande A, McArthur C, Kumar A, Kumar S (2013) Tobacco smoking effect on HIV-1 pathogenesis: role of cytochrome P450 isozymes. Expert Opin Drug Metab Toxicol 9:1453–1464

Andersson U, Tracey KJ (2012) Reflex principles of immunological homeostasis. Annu Rev Immunol 30:313–335

Baez-Pagan CA, Delgado-Velez M, Lasalde-Dominicci JA (2015) Activation of the Macrophage alpha7 Nicotinic Acetylcholine Receptor and Control of Inflammation. J Neuroimmune Pharmacol 10:468–476

Barbaro G, Scozzafava A, Mastrolorenzo A, Supuran CT (2005) Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome. Curr Pharm Des 11:1805–1843

Benowitz NL (2009) Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49:57–71

Benowitz NL (2010) Nicotine addiction. N Engl J Med 362:2295–2303

Borjabad A, Volsky DJ (2012) Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis. J Neuroimmune Pharmacol 7:914–926

Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527–530

Bracci L, Lozzi L, Rustici M, Neri P (1992) Binding of HIV-1 gp120 to the nicotinic receptor. FEBS Lett 311:115–118

Brehm MA, Shultz LD, Luban J, Greiner DL (2013) Overcoming Current Limitations in Humanized Mouse Research. J Infect Dis 208:S125–S130

Bryant VE, Kahler CW, Devlin KN, Monti PM, Cohen RA (2013) The effects of cigarette smoking on learning and memory performance among people living with HIV/AIDS. AIDS Care 25:1308–1316

Cao J, Wang S, Wang J, Cui W, Nesil T, Vigorito M, Chang SL, Li MD (2013) RNA deep sequencing analysis reveals that nicotine restores impaired gene expression by viral proteins in the brains of HIV-1 transgenic rats. PLoS One 8:e68517

Cao J, Nesil T, Wang S, Chang SL, Li MD (2016) Expression profile of nicotinic acetylcholine receptor subunits in the brain of HIV-1 transgenic rats given chronic nicotine treatment. J Neurovirol 22:626–633

Cardinale A, Nastrucci C, Cesario A, Russo P (2012) Nicotine: specific role in angiogenesis, proliferation and apoptosis. Crit Rev Toxicol 42:68–89

Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, Lewis CE, Ockene JK, Prentice RL, Speizer FE, Thun MJ, Jacobs EJ (2015) Smoking and mortality--beyond established causes. N Engl J Med 372:631–640

Centers for Disease C, Prevention, National Center for Chronic Disease P, Health P, Office on S, Health (2010) Publications and Reports of the Surgeon General. In: How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Centers for Disease Control and Prevention (US), Atlanta

Chang SL, Connaghan KP (2012) Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins. J Neuroimmune Pharmacol 7:332–340

Chang JR, Mukerjee R, Bagashev A, Del Valle L, Chabrashvili T, Hawkins BJ, He JJ, Sawaya BE (2011) HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. J Biol Chem 286:41125–41134

Chang SL, Connaghan KP, Wei Y, Li MD (2014) NeuroHIV and use of addictive substances. Int Rev Neurobiol 118:403–440

Chang L, Lim A, Lau E, Alicata D (2017) Chronic Tobacco-Smoking on Psychopathological Symptoms, Impulsivity and Cognitive Deficits in HIV-Infected Individuals. J Neuroimmune Pharmacol 12:389–401

Choi J, Liu RM, Kundu RK, Sangiorgi F, Wu W, Maxson R, Forman HJ (2000) Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice. J Biol Chem 275:3693–3698

Clary CR, Guidot DM, Bratina MA, Otis JS (2011) Chronic alcohol ingestion exacerbates skeletal muscle myopathy in HIV-1 transgenic rats. AIDS Res Ther 8:30

Cohen RA, Seider TR, Navia B (2015) HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? Alzheimers Res Ther 7:37

Colina R, Costa-Mattioli M, Dowling RJ, Jaramillo M, Tai LH, Breitbach CJ, Martineau Y, Larsson O, Rong L, Svitkin YV, Makrigiannis AP, Bell JC, Sonenberg N (2008) Translational control of the innate immune response through IRF-7. Nature 452:323–328

Cui WY, Li MD (2010) Nicotinic modulation of innate immune pathways via alpha7 nicotinic acetylcholine receptor. J Neuroimmune Pharmacol 5:479–488

Cui WY, Wang J, Wei J, Cao J, Chang SL, Gu J, Li MD (2012) Modulation of innate immune-related pathways in nicotine-treated SH-SY5Y cells. Amino Acids 43:1157–1169

Cui WY, Zhao S, Polanowska-Grabowska R, Wang J, Wei J, Dash B, Chang SL, Saucerman JJ, Gu J, Li MD (2013) Identification and characterization of poly(I:C)-induced molecular responses attenuated by nicotine in mouse macrophages. Mol Pharmacol 83:61–72

Delgado-Velez M, Baez-Pagan CA, Gerena Y, Quesada O, Santiago-Perez LI, Capo-Velez CM, Wojna V, Melendez L, Leon-Rivera R, Silva W, Lasalde-Dominicci JA (2015) The alpha7-nicotinic receptor is upregulated in immune cells from HIV-seropositive women: consequences to the cholinergic anti-inflammatory response. Clin Transl Immunology 4:e53

DeVaughn S, Muller-Oehring EM, Markey B, Bronte-Stewart HM, Schulte T (2015) Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease. Neuropsychol Rev 25:424–438

Durazzo TC, Mattsson N, Weiner MW (2014) Smoking and increased Alzheimer's disease risk: a review of potential mechanisms. Alzheimers Dement 10:S122–S145

Fan X, Joshi PC, Koval M, Guidot DM (2011) Chronic alcohol ingestion exacerbates lung epithelial barrier dysfunction in HIV-1 transgenic rats. Alcohol Clin Exp Res 35:1866–1875

Fauci AS, Folkers GK (2012) Toward an aids-free generation. JAMA 308:343–344

Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, Gandhi M, Mocharnuk RS, Anastos K (2006) Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health 96:1060–1065

Fratiglioni L, Wang HX (2000) Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies. Behav Brain Res 113:117–120

Frieden TR, Foti KE, Mermin J (2015) Applying Public Health Principles to the HIV Epidemic — How Are We Doing? N Engl J Med 373:2281–2287

Gannon P, Khan MZ, Kolson DL (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 24:275–283

Garlanda C, Dinarello CA, Mantovani A (2013) The interleukin-1 family: back to the future. Immunity 39:1003–1018

Giunta B, Ehrhart J, Townsend K, Sun N, Vendrame M, Shytle D, Tan J, Fernandez F (2004) Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. Brain Res Bull 64:165–170

Gonda MA, Luther DG, Fong SE, Tobin GJ (1994) Bovine immunodeficiency virus: molecular biology and virus-host interactions. Virus Res 32:155–181

Gonzalez-Lira B, Rueda-Orozco PE, Galicia O, Montes-Rodriguez CJ, Guzman K, Guevara-Martinez M, Elder JH, Prospero-Garcia O (2006) Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats. Neurosci Lett 394:136–139

Gonzalez-Scarano F, Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5:69–81

Guo M, Ho WZ (2014) Animal models to study Mycobacterium tuberculosis and HIV co-infection. Dong wu xue yan jiu =. Zool Res 35:163–169

Hedstrom AK, Hillert J, Olsson T, Alfredsson L (2013) Nicotine might have a protective effect in the etiology of multiple sclerosis. Mult Scler (Houndmills, Basingstoke, England) 19:1009-1013.

Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, Nordestgaard BG, Obel N (2013) Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis 56:727–734

Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8:382–397

Homji NF, Vigorito M, Chang SL (2012) Morphine-induced conditioned place preference and associated behavioural plasticity in HIV-1 transgenic rats. Int J Clin Exp Med 5:105–123

Hong S, Banks WA (2015) Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications. Brain Behav Immun 45:1–12

Hu Y, Pan Z, Hu Y, Zhang L, Wang J (2017a) Network and Pathway-Based Analyses of Genes Associated with Parkinson's Disease. Mol Neurobiol 54:4452–4465

Hu YS, Xin J, Hu Y, Zhang L, Wang J (2017b) Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach. Alzheimers Res Ther 9:29

Ingram JR (2009) Nicotine: does it have a role in the treatment of skin disease? Postgrad Med J 85:196–201

Ito R, Takahashi T, Katano I, Ito M (2012) Current advances in humanized mouse models. Cell Mol Immunol 9:208–214

Jaakkola MS, Jaakkola JJ (1997) Assessment of exposure to environmental tobacco smoke. Eur Respir J 10:2384–2397

Jaeger LB, Nath A (2012) Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis. Disease Models &amp. Mechanisms 5:313–322

Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM (2016) Current Cigarette Smoking Among Adults - United States, 2005-2015. MMWR Morb Mortal Wkly Rep 65:1205–1211

Jiang T, Sun Q, Chen S (2016) Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease. Prog Neurobiol 147:1–19

Joseph J, Colosi DA, Rao VR (2016) HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities. Curr HIV Res 14:389–399

Kalkman HO, Feuerbach D (2016) Modulatory effects of alpha7 nAChRs on the immune system and its relevance for CNS disorders. Cell Mol Life Sci 73:2511–2530

Kass MD, Liu X, Vigorito M, Chang L, Chang SL (2010) Methamphetamine-induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats. J Neuroimmune Pharmacol 5:566–573

Kawamata J, Shimohama S (2011) Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis 24(Suppl 2):95–109

Kawamata J, Suzuki S, Shimohama S (2012) Alpha7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease. Curr Drug Targets 13:623–630

Kim BO, Liu Y, Ruan Y, Xu ZC, Schantz L, He JJ (2003) Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline. Am J Pathol 162:1693–1707

Kori M, Aydin B, Unal S, Arga KY, Kazan D (2016) Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. OMICS 20:645–661

Koutsilieri E, Sopper S, Scheller C, ter Meulen V, Riederer P (2002) Parkinsonism in HIV dementia. J Neural Transm (Vienna, Austria : 1996) 109:767-775.

Krebs FC, Ross H, McAllister J, Wigdahl B (2000) HIV-1-associated central nervous system dysfunction. Adv Pharmacol 49:315–385

Krucker T, Toggas SM, Mucke L, Siggins GR (1998) Transgenic mice with cerebral expression of human immunodeficiency virus type-1 coat protein gp120 show divergent changes in short- and long-term potentiation in CA1 hippocampus. Neuroscience 83:691–700

Laboratories ACfDCaPaAoPH (2014) Laboratory testing for the diagnosis of HIV infection: updated recommendations

Lashomb AL, Vigorito M, Chang SL (2009) Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neurovirol 15:14–24

Lee M-H, Wang T, Jang M-H, Steiner J, Haughey N, G-l M, Song H, Nath A, Venkatesan A (2011) Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease. Neurobiol Dis 41:678–687

Levine AJ, Miller JA, Shapshak P, Gelman B, Singer EJ, Hinkin CH, Commins D, Morgello S, Grant I, Horvath S (2013) Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease. BMC Med Genet 6:4

Li MD, Cao J, Wang S, Wang J, Sarkar S, Vigorito M, Ma JZ, Chang SL (2013) Transcriptome sequencing of gene expression in the brain of the HIV-1 transgenic rat. PLoS One 8:e59582

Lifson AR, Lando HA (2012) Smoking and HIV: prevalence, health risks, and cessation strategies. Curr HIV/AIDS Rep 9:223–230

Li-Sha G, Jing-Lin Z, Guang-Yi C, Li L, De-Pu Z, Yue-Chun L (2015) Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3. Sci Rep 5:15895

Liu X, Chang L, Vigorito M, Kass M, Li H, Chang SL (2009) Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat. J Neuroimmune Pharmacol 4:309–316

Lucas S-M, Rothwell NJ, Gibson RM (2006) The role of inflammation in CNS injury and disease. Br J Pharmacol 147:S232–S240

Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fatkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD (2015) Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 373:795–807

Marcus JL, Chao CR, Leyden WA, Xu L, Quesenberry CP Jr, Klein DB, Towner WJ, Horberg MA, Silverberg MJ (2016) Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care. J Acquir Immune Defic Syndr 73:39–46

Markou A (2008) Review. Neurobiology of nicotine dependence. Philos Trans R Soc Lond Ser B Biol Sci 363:3159–3168

Marshall MM, McCormack MC, Kirk GD (2009) Effect of cigarette smoking on HIV acquisition, progression, and mortality. AIDS Educ Prev 21:28–39

Maung R, Medders KE, Sejbuk NE, Desai MK, Russo R, Kaul M (2012) Genetic Knockouts Suggest a Critical Role for HIV Co-Receptors in Models of HIV gp120-Induced Brain Injury. J Neuroimmune Pharmacol 7:306–318

McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N (2003) Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 9:205–221

McClernon FJ, Hiott FB, Westman EC, Rose JE, Levin ED (2006) Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. Psychopharmacology 189:125–133

McLaurin KA, Booze RM, Mactutus CF (2016) Progression of temporal processing deficits in the HIV-1 transgenic rat. Sci Rep 6:32831

McLaurin KA, Booze RM, Mactutus CF (2017) Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1. J Neurovirol 23:87–98

Mdodo R, Frazier EL, Dube SR, Mattson CL, Sutton MY, Brooks JT, Skarbinski J (2015) Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med 162:335–344

Micci L, McGary CS, Paiardini M (2015) Animal models in HIV cure research. Journal of virus eradication 1:17–22

Midde NM, Gomez AM, Harrod SB, Zhu J (2011) Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats. Pharmacol Biochem Behav 98:587–597

Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C (2002) The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 202:13–23

Moran LM, Aksenov MY, Booze RM, Webb KM, Mactutus CF (2012) Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Curr HIV Res 10:415–424

Moran LM, Booze RM, Webb KM, Mactutus CF (2013) Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction. Exp Neurol 239:139–147

Nath A (2002) Human Immunodeficiency Virus (HIV) Proteins in Neuropathogenesis of HIV Dementia. J Infect Dis 186:S193–S198

Nesil T, Cao J, Yang Z, Chang SL, Li MD (2015) Nicotine attenuates the effect of HIV-1 proteins on the neural circuits of working and contextual memories. Mol Brain 8:43

Nischang M, Gers-Huber G, Audige A, Akkina R, Speck RF (2012) Modeling HIV infection and therapies in humanized mice. Swiss Med Wkly 142:w13618

Nordberg A, Hellstrom-Lindahl E, Lee M, Johnson M, Mousavi M, Hall R, Perry E, Bednar I, Court J (2002) Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). J Neurochem 81:655–658

Nunomura A, Moreira PI, Lee HG, Zhu X, Castellani RJ, Smith MA, Perry G (2007) Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol Disord Drug Targets 6:411–423

Olmsted RA, Hirsch VM, Purcell RH, Johnson PR (1989) Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. Proc Natl Acad Sci U S A 86:8088–8092

Peng J, Vigorito M, Liu X, Zhou D, Wu X, Chang SL (2010) The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol 218:94–101

Petrosillo N, Cicalini S (2013) Smoking and HIV: time for a change? BMC Med 11:16

Piao WH, Campagnolo D, Dayao C, Lukas RJ, Wu J, Shi FD (2009) Nicotine and inflammatory neurological disorders. Acta Pharmacol Sin 30:715–722

Picciotto MR, Zoli M (2008) Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease. Front Biosci 13:492–504

Policicchio BB, Pandrea I, Apetrei C (2016) Animal Models for HIV Cure Research. Front Immunol 7:12

Quik M, Perez XA, Bordia T (2012) Nicotine as a potential neuroprotective agent for Parkinson's disease. Mov Disord 27:947–957

Ray PE, Liu XH, Robinson LR, Reid W, Xu L, Owens JW, Jones OD, Denaro F, Davis HG, Bryant JL (2003) A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy. Kidney Int 63:2242–2253

Reid W et al (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci 98:9271–9276

Reid W, Abdelwahab S, Sadowska M, Huso D, Neal A, Ahearn A, Bryant J, Gallo RC, Lewis GK, Reitz M (2004) HIV-1 transgenic rats develop T cell abnormalities. Virology 321:111–119

Reid WC, Ibrahim WG, Kim SJ, Denaro F, Casas R, Lee DE, Maric D, Hammoud DA (2016) Characterization of neuropathology in the HIV-1 transgenic rat at different ages. J Neuroimmunol 292:116–125

Rezvani AH, Levin ED (2001) Cognitive effects of nicotine. Biol Psychiatry 49:258–267

Rock RB, Gekker G, Aravalli RN, Hu S, Sheng WS, Peterson PK (2008) Potentiation of HIV-1 expression in microglial cells by nicotine: involvement of transforming growth factor-beta 1. J Neuroimmune Pharmacol 3:143–149

Rosas-Ballina M, Tracey KJ (2009) Cholinergic control of inflammation. J Intern Med 265:663–679

Royal W 3rd, Can A, Gould TD, Guo M, Huse J, Jackson M, Davis H, Bryant J (2018) Cigarette smoke and nicotine effects on brain proinflammatory responses and behavioral and motor function in HIV-1 transgenic rats. J Neurovirol 24:246–253

Sacktor N (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8(Suppl 2):115–121

Sagar V, Pilakka-Kanthikeel S, Martinez PC, Atluri VSR, Nair M (2017) Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS. PLoS One 12:e0181642

Sarkar S, Chang SL (2013) Ethanol concentration-dependent alterations in gene expression during acute binge drinking in the HIV-1 transgenic rat. Alcohol Clin Exp Res 37:1082–1090

Sarkar S, Mao X, Liu C, Chang SL (2013) Age- and ethanol concentration-dependent effects of acute binge drinking in the HIV-1 transgenic rat. Alcohol Clin Exp Res 37(Suppl 1):E70–E78

Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol 12:234–248

Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA (1999) Control of Viremia in Simian Immunodeficiency Virus Infection by CD8⁺ Lymphocytes. Science 283:857–860

Sharma G, Vijayaraghavan S (2001) Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci U S A 98:4148–4153

Shi FD, Piao WH, Kuo YP, Campagnolo DI, Vollmer TL, Lukas RJ (2009) Nicotinic attenuation of central nervous system inflammation and autoimmunity. J Immunol (Baltimore, Md : 1950 182:1730–1739

Shimohama S (2009) Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models. Biol Pharm Bull 32:332–336

Shuter J, Pearlman BK, Stanton CA, Moadel AB, Kim RS, Weinberger AH (2016) Gender Differences among Smokers Living with HIV. J Int Assoc Provid AIDS Care 15:412–417

Sliva K (2015) Latest animal models for anti-HIV drug discovery. Expert Opin Drug Discovery 10:111–123

Sopori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2:372–377

Stampfli MR, Anderson GP (2009) How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 9:377–384

Steinbrook R (2016) Hiv/aids in 2016 and beyond. JAMA 316:1139–1140

Swan GE, Lessov-Schlaggar CN (2007) The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev 17:259–273

Tizabi Y, Overstreet DH, Rezvani AH, Louis VA, Clark E Jr, Janowsky DS, Kling MA (1999) Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology 142:193–199

Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188–193

Tracey KJ (2009) Reflex control of immunity. Nat Rev Immunol 9:418–428

Tuesta LM, Fowler CD, Kenny PJ (2011) Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem Pharmacol 82:984–995

UNAIDS (2015) People living with HIV. In: UNAIDS.

Valcour V, Sithinamsuwan P, Letendre S, Ances B (2011) Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep 8:54–61

Vellutini C, Horschowski N, Philippon V, Gambarelli D, Nave KA, Filippi P (1995) Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene. AIDS Res Hum Retrovir 11:21–29

Vigano A, Trabattoni D, Schneider L, Ottaviani F, Aliffi A, Longhi E, Rusconi S, Clerici M (2006) Failure to eradicate HIV despite fully successful HAART initiated in the first days of life. J Pediatr 148:389–391

Vigorito M, LaShomb AL, Chang SL (2007) Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol 2:319–328

Vigorito M, Connaghan KP, Chang SL (2015) The HIV-1 transgenic rat model of neuroHIV. Brain Behav Immun 48:336–349

Waisman A, Liblau RS, Becher B (2015) Innate and adaptive immune responses in the CNS. The Lancet Neurology 14:945–955

Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10:1216–1221

Wang H et al (2016) Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. The lancet HIV 3:e361–e387

Weiner HL, Selkoe DJ (2002) Inflammation and therapeutic vaccination in CNS diseases. Nature 420:879–884

Wingo T, Nesil T, Chang SL, Li MD (2016) Interactive Effects of Ethanol and HIV-1 Proteins on Novelty-Seeking Behaviors and Addiction-Related Gene Expression. Alcohol Clin Exp Res 40:2102–2113

Wojna V, Skolasky RL, Hechavarria R, Mayo R, Selnes O, McArthur JC, Melendez LM, Maldonado E, Zorrilla CD, Garcia H, Kraiselburd E, Nath A (2006) Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol 12:356–364

Wojna V, Robles L, Skolasky RL, Mayo R, Selnes O, de la Torre T, Maldonado E, Nath A, Melendez LM, Lasalde-Dominicci J (2007) Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women. J Neurovirol 13:561–568

Xu J, Ikezu T (2009) The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era. J Neuroimmune Pharmacol 4:200–212

Yang Z, Nesil T, Connaghan KP, Li MD, Chang SL (2016) Modulation Effect of HIV-1 Viral Proteins and Nicotine on Expression of the Immune-Related Genes in Brain of the HIV-1 Transgenic Rats. J Neuroimmune Pharmacol 11:562–571

Yang Z, Nesil T, Wingo T, Chang SL, Li MD (2017) HIV-1 Proteins Influence Novelty-Seeking Behavior and Alter Region-Specific Transcriptional Responses to Chronic Nicotine Treatment in HIV-1Tg Rats. Nicotine Tob Res

Yoshikawa H, Kurokawa M, Ozaki N, Nara K, Atou K, Takada E, Kamochi H, Suzuki N (2006) Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol 146:116–123

Yoshioka M, Itoyama Y (1997) Pathogenesis of HIV-1-associated-neurologic diseases. Nihon Rinsho 55:897–903